Close

Analyst Ratings for Fate Therapeutics (FATE)

FATE Rating Summary

FATE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on FATE
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $7.44 (+32%) * Over Last 12-Mos
Rating Score: 3.5 / 10   Percentile Rank: 33%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/27/2023 Wells Fargo
» Updated 11/9/2023
Yanan Zhu New Coverage Equal Weight
(N/A)
5.00
(6.00)
5.39
(5.64)
4.64% Details
1/24/2023 H.C. Wainwright Debjit Chattopadhyay Downgrade Neutral
(Buy)
N/A
(N/A)
5.55
(5.64)
1.62% Details
Like FATE Ratings? Also take a look at FAT, CRNX

FATE Ratings News